
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/base_style-CPPDhfna.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-BepKMsUl.js"></script>

  <link rel="stylesheet" href="/static/assets/article_style-DUfI1jZp.css" />
<link rel="stylesheet" href="/static/assets/style-BOrsu84o.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-D3wJHomh.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Pharmacogenetics and adverse drug reports: Insights from a United Kingdom national pharmacovigilance database - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="E0CA2612930B29F3002612000D98E18F.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="plosmed">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11949333/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="PLOS Medicine">
<meta name="citation_title" content="Pharmacogenetics and adverse drug reports: Insights from a United Kingdom national pharmacovigilance database">
<meta name="citation_author" content="Emma F Magavern">
<meta name="citation_author_institution" content="William Harvey Research Institute, Queen Mary University of London, London, United Kingdom">
<meta name="citation_author" content="Maia Megase">
<meta name="citation_author_institution" content="William Harvey Research Institute, Queen Mary University of London, London, United Kingdom">
<meta name="citation_author" content="Jack Thompson">
<meta name="citation_author_institution" content="Department of Clinical Toxicology and General Medicine, St Thomas’ Hospital, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom">
<meta name="citation_author" content="Gabriel Marengo">
<meta name="citation_author_institution" content="William Harvey Research Institute, Queen Mary University of London, London, United Kingdom">
<meta name="citation_author" content="Julius Jacobsen">
<meta name="citation_author_institution" content="William Harvey Research Institute, Queen Mary University of London, London, United Kingdom">
<meta name="citation_author" content="Damian Smedley">
<meta name="citation_author_institution" content="William Harvey Research Institute, Queen Mary University of London, London, United Kingdom">
<meta name="citation_author" content="Mark J Caulfield">
<meta name="citation_author_institution" content="William Harvey Research Institute, Queen Mary University of London, London, United Kingdom">
<meta name="citation_publication_date" content="2025 Mar 27">
<meta name="citation_volume" content="22">
<meta name="citation_issue" content="3">
<meta name="citation_firstpage" content="e1004565">
<meta name="citation_doi" content="10.1371/journal.pmed.1004565">
<meta name="citation_pmid" content="40146782">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11949333/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11949333/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11949333/pdf/pmed.1004565.pdf">
<meta name="description" content="Adverse drug reactions (ADRs) harm patients and are costly for healthcare systems. Genetic variation contributes to variability in medication response and prospective knowledge of these variants can decrease risk of ADRs, as shown in the PREPARE ...">
<meta name="og:title" content="Pharmacogenetics and adverse drug reports: Insights from a United Kingdom national pharmacovigilance database">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Adverse drug reactions (ADRs) harm patients and are costly for healthcare systems. Genetic variation contributes to variability in medication response and prospective knowledge of these variants can decrease risk of ADRs, as shown in the PREPARE ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11949333/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="11949333">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1371/journal.pmed.1004565"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/pmed.1004565.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11949333%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/11949333/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/11949333/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC11949333/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-plosmed.png" alt="PLOS Medicine logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to PLOS Medicine" title="Link to PLOS Medicine" shape="default" href="https://doi.org/10.1371/journal.pmed.1004565" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">PLoS Med</button></div>. 2025 Mar 27;22(3):e1004565. doi: <a href="https://doi.org/10.1371/journal.pmed.1004565" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pmed.1004565</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22PLoS%20Med%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22PLoS%20Med%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22PLoS%20Med%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22PLoS%20Med%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Pharmacogenetics and adverse drug reports: Insights from a United Kingdom national pharmacovigilance database</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Magavern%20EF%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Emma F Magavern</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Emma F Magavern</span></h3>
<div class="p">
<sup>1</sup>William Harvey Research Institute, Queen Mary University of London, London, United Kingdom</div>
<div>Conceptualization, Data curation, Formal analysis, Methodology, Validation, Visualization, Writing – original draft, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Magavern%20EF%22%5BAuthor%5D" class="usa-link"><span class="name western">Emma F Magavern</span></a>
</div>
</div>
<sup>1,</sup><sup>*,</sup><sup>‡</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Megase%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Maia Megase</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Maia Megase</span></h3>
<div class="p">
<sup>1</sup>William Harvey Research Institute, Queen Mary University of London, London, United Kingdom</div>
<div>Data curation, Formal analysis</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Megase%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Maia Megase</span></a>
</div>
</div>
<sup>1,</sup><sup>‡</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Thompson%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Jack Thompson</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Jack Thompson</span></h3>
<div class="p">
<sup>2</sup>Department of Clinical Toxicology and General Medicine, St Thomas’ Hospital, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom</div>
<div>Data curation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Thompson%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jack Thompson</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Marengo%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Gabriel Marengo</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Gabriel Marengo</span></h3>
<div class="p">
<sup>1</sup>William Harvey Research Institute, Queen Mary University of London, London, United Kingdom</div>
<div>Data curation, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Marengo%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Gabriel Marengo</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jacobsen%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Julius Jacobsen</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Julius Jacobsen</span></h3>
<div class="p">
<sup>1</sup>William Harvey Research Institute, Queen Mary University of London, London, United Kingdom</div>
<div>Data curation, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jacobsen%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Julius Jacobsen</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Smedley%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Damian Smedley</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Damian Smedley</span></h3>
<div class="p">
<sup>1</sup>William Harvey Research Institute, Queen Mary University of London, London, United Kingdom</div>
<div>Supervision, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Smedley%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Damian Smedley</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Caulfield%20MJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Mark J Caulfield</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Mark J Caulfield</span></h3>
<div class="p">
<sup>1</sup>William Harvey Research Institute, Queen Mary University of London, London, United Kingdom</div>
<div>Supervision, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Caulfield%20MJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Mark J Caulfield</span></a>
</div>
</div>
<sup>1</sup>
</div>
<div class="cg p">Editor: <span class="name western">Seena Fazel</span><sup>3</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff001">
<sup>1</sup>William Harvey Research Institute, Queen Mary University of London, London, United Kingdom</div>
<div id="aff002">
<sup>2</sup>Department of Clinical Toxicology and General Medicine, St Thomas’ Hospital, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom</div>
<div id="edit1">
<sup>3</sup>University of Oxford, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND</div>
<div class="author-notes p">
<div class="fn" id="coi001"><p>The authors have declared that no competing interests exist.</p></div>
<div class="fn" id="econtrib001"><p>‡ These authors are joint first authors on this work.</p></div>
<div class="fn" id="cor001">
<sup>✉</sup><p class="display-inline">* E-mail: <span>e.magavern@qmul.ac.uk</span></p>
</div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Emma F Magavern</span></strong>: <span class="role">Conceptualization, Data curation, Formal analysis, Methodology, Validation, Visualization, Writing – original draft, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Maia Megase</span></strong>: <span class="role">Data curation, Formal analysis</span>
</div>
<div>
<strong class="contrib"><span class="name western">Jack Thompson</span></strong>: <span class="role">Data curation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Gabriel Marengo</span></strong>: <span class="role">Data curation, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Julius Jacobsen</span></strong>: <span class="role">Data curation, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Damian Smedley</span></strong>: <span class="role">Supervision, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Mark J Caulfield</span></strong>: <span class="role">Supervision, Writing – review &amp; editing</span>
</div>
<div class="p">
<strong class="contrib"><span class="name western">Seena Fazel</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Sep 17; Accepted 2025 Feb 21; Collection date 2025 Mar.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 Magavern et al</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC11949333  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40146782/" class="usa-link">40146782</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec014"><h3 class="pmc_sec_title">Background</h3>
<p>Adverse drug reactions (ADRs) harm patients and are costly for healthcare systems. Genetic variation contributes to variability in medication response and prospective knowledge of these variants can decrease risk of ADRs, as shown in the PREPARE trial. Reduction in ADRs would affect only those reactions to drugs contained in well-validated pharmacogene–drug pairs. The scope of ADRs represented by these drugs on a population scale is unclear. The objective of this study was to characterize the pharmacogene–drug-associated ADR reporting landscape from a national regulatory pharmacovigilance dataset to elucidate the scale of potential ADR mitigation by pharmacogenomics (PGx) implementation.</p></section><section id="sec015"><h3 class="pmc_sec_title">Methods and findings</h3>
<p>All publicly available Yellow Card ADR reports to the United Kingdom Medicines and Healthcare Products Regulatory Agency, from 1963 to 2024, were compiled using programmatic data extraction. The ADRs were analysed with descriptive statistics, stratified by PGx status and by associated genes. Prescribing prevalence from the literature was compared with age range matched ADR reports for PGx-associated drugs. </p>
<p>There were 1,345,712 ADR reports, attributed to 2,499 different substances. 115,789 adverse drug reports (9%) were associated with drugs for which ADR risk can be modified based on pharmacogenomic prescribing guidance. Seventy-five percent of these (<em>n</em> = 87,339) were due to medicines which interact with only three pharmacokinetic pharmacogenes (<em>CYP2C19</em>, <em>CYP2D6</em>, <em>SLCO1B1</em>). Forty-seven percent of all the PGx mitigatable ADRs identified were attributed to psychiatric medications (<em>n</em> = 54,846), followed by 24% attributed to cardiovascular medications (<em>n</em> = 28,279). Those experiencing PGx mitigatable ADRs, as compared with non-PGx mitigatable ADRs, were older and the ADRs more often consisted of severe non-fatal reactions. Many PGx-associated psychiatric drug ADRs were overrepresented as compared with prescribing prevalence, but fatal cardiac arrhythmias were uncommon consequences, comprising only 0.4% of these ADRs (<em>n</em> = 172 of <em>n</em> = 48,315 total ADRs). </p>
<p>Limitations of this data source include under reporting of ADRs and reporting bias. These findings are based on analysis of the Yellow Card dataset described and may not represent all ADRs from a generalised patient population.</p></section><section id="sec016"><h3 class="pmc_sec_title">Conclusions</h3>
<p>Nine percent of all reported ADRs are associated with drugs where a genetic variant can cause heightened risk of an ADR and inform prescribing. A panel of only three pharmacogenes could potentially mitigate three in every four PGx modifiable ADRs. Based on our findings, Psychiatry may be the single highest impact specialty to pilot PGx to reduce ADRs and associated morbidity, mortality and costs.</p></section></section><section class="abstract" id="abstract2"><h2>Author summary</h2>
<section id="sec017"><h3 class="pmc_sec_title">Why was this study done?</h3>
<ul class="list" style="list-style-type:disc">
<li><p>Side effects to medications (adverse drug reactions (ADRs)) are common and can be dangerous.</p></li>
<li><p>Though some side effects could be avoided by personalising prescribing based on genetic variants (pharmacogenonomics (PGx)) it is not clear what volume of side effects are reported from medications that could be personalised using this approach.</p></li>
<li><p>This study used the United Kingdom national side effect reporting system, called the Yellow Card reports, to estimate the volume of ADRs that could be impacted on with personalised prescribing from the past 60 years.</p></li>
</ul></section><section id="sec018"><h3 class="pmc_sec_title">What did the researchers do and find?</h3>
<ul class="list" style="list-style-type:disc">
<li><p>All publicly available Yellow Card reports to the United Kingdom Medicines and Healthcare Products Regulatory Agency from, 1963 to 2024, were compiled and analysed. Prescribing prevalence from the literature was compared with side effect reports for PGx-associated drugs.</p></li>
<li><p>There were over 1 million reports of side effects to medications, attributed to more than 2000 different substances. Nine percent of these reported side effects were associated with drugs for which side effect risk can be modified using genetic information to guide prescribing.</p></li>
<li><p>Seventy-five percent of these PGx mitigateble side effects were associated with medicines which interact with only three genes that impact how the body processes medication (<em>CYP2C19</em>, <em>CYP2D6</em>, <em>SLCO1B1</em>).</p></li>
<li><p>Forty-seven percent of all the PGx mitigatable side effects identified were attributed to psychiatric medications, followed by 24% attributed to cardiovascular medications. Reported side effect to many PGx-associated psychiatric drugs were overrepresented as compared with how commonly the medications were prescribed.</p></li>
</ul></section><section id="sec019"><h3 class="pmc_sec_title">What do these findings mean?</h3>
<ul class="list" style="list-style-type:disc">
<li><p>Nine percent of all spontaneously reported side effects are associated with drugs where a genetic variant can cause heightened risk of a side effect and inform prescribing.</p></li>
<li><p>Using a panel of only three genes could potentially mitigate three in every four PGx modifiable side effects.</p></li>
<li><p>Based on our findings, Psychiatry may be the single highest impact specialty to pilot pharmacogenomics to reduce side effects.</p></li>
<li><p>This study is based on the reports submitted voluntarily by healthcare practitioners and members of the public to the database and may not represent all ADRs.</p></li>
</ul></section></section><section class="abstract" id="abstract3"><hr class="headless">
<p>Emma F Magavern, Maia Megase and colleagues use Yellow Card reports from the past 60 years to estimate the volume of adverse drug reactions that could be targeted by personalised prescribing based on pharmacogenomics.</p></section><section id="sec001"><h2 class="pmc_sec_title">Introduction</h2>
<p>There is significant variability in interindividual response to medication. Some of this variable response, which contributes to adverse drug reactions (ADRs), is due to interaction between genetic variants and medications [<a href="#pmed.1004565.ref001" class="usa-link" aria-describedby="pmed.1004565.ref001">1</a>]. This is often referred to as pharmacogenomics (PGx). Population scale studies have shown that 99.5% of individuals have genetic variants which could lead to an atypical drug response [<a href="#pmed.1004565.ref002" class="usa-link" aria-describedby="pmed.1004565.ref002">2</a>].</p>
<p>ADRs are common and costly, impacting heavily on patient quality of life, medication adherence, and even morbidity and mortality [<a href="#pmed.1004565.ref003" class="usa-link" aria-describedby="pmed.1004565.ref003">3</a>]. Recent estimates place the cost of ADRs at greater than 2.2 billion pounds per annum in the United Kingdom (UK), and ADRs are estimated to represent 6.5% of all acute hospital admissions [<a href="#pmed.1004565.ref004" class="usa-link" aria-describedby="pmed.1004565.ref004">4</a>,<a href="#pmed.1004565.ref005" class="usa-link" aria-describedby="pmed.1004565.ref005">5</a>].</p>
<p>As the population in the UK ages, a trend seen in many high income countries, patients are living longer with more medical morbidities, contributing to both appropriate and inappropriate polypharmacy [<a href="#pmed.1004565.ref006" class="usa-link" aria-describedby="pmed.1004565.ref006">6</a>–<a href="#pmed.1004565.ref008" class="usa-link" aria-describedby="pmed.1004565.ref008">8</a>]. This has led to an increase in number of prescriptions dispensed nationally between the last two census points [<a href="#pmed.1004565.ref009" class="usa-link" aria-describedby="pmed.1004565.ref009">9</a>,<a href="#pmed.1004565.ref010" class="usa-link" aria-describedby="pmed.1004565.ref010">10</a>]. An estimated 3.8 million people in England alone take eight or more medicines [<a href="#pmed.1004565.ref007" class="usa-link" aria-describedby="pmed.1004565.ref007">7</a>]. These population level trends highlight the importance of reducing risk factors for ADRs and have led to a surge in interest in PGx implementation whereby prospective genotyping enables personalised prescribing.</p>
<p>Prospective clinical trial evidence from the U-PGx group (PREPARE trial—Pre-emptive Pharmacogenomic Testing for Preventing ADRs) shows that implementation of a PGx panel can reduce ADRs by 30% [<a href="#pmed.1004565.ref011" class="usa-link" aria-describedby="pmed.1004565.ref011">11</a>]. Internationally recognised PGx consortia guidelines, such as those produced by the Dutch Pharmacogenetics Working Group (DPWG) (implemented by the PREPARE trial) or the Clinical Pharmacogenetics Implementation Consortium (CPIC), provide clinically actionable guidance for a subset of drugs with well validated drug–gene relationships [<a href="#pmed.1004565.ref012" class="usa-link" aria-describedby="pmed.1004565.ref012">12</a>,<a href="#pmed.1004565.ref013" class="usa-link" aria-describedby="pmed.1004565.ref013">13</a>]. The scope of ADRs arising from drugs with PGx guidance in the context of all reported ADRs across a population is currently unclear. None of the regulators, to our knowledge, have reported retrospectively on the percentage and composition of reporting for drugs with PGx indications. We have retrospectively analysed all Yellow Card ADR reports published by the UK Medicines and Healthcare Product Regulatory Agency (MHRA), encompassing reports from 1963 to 2024, to address this gap in knowledge.</p>
<p>The objective of this study was to characterize the pharmacogene–drug-associated ADR reporting landscape from a national regulatory pharmacovigilance dataset to elucidate the scale of potential ADR mitigation by PGx implementation in the UK. Furthermore, we explored a possible association between demographic variables and ADR reports which can be mitigated by implementation of PGx. Such knowledge may impact on choice of initial PGx implementation settings in the UK.</p></section><section id="sec002"><h2 class="pmc_sec_title">Methods</h2>
<section id="sec003"><h3 class="pmc_sec_title">Data source: Yellow Card reports</h3>
<p>The UK MHRA established the Yellow Card reporting system in the 1960s following the Thalidomide tragedy, thereby creating a national pharmacovigilance system to ensure medication safety. These reports for ADRs can be submitted by patients themselves, carers, or healthcare practitioners as well as by industry teams. The MHRA makes these reports publicly available on their website via interactive drug analysis profiles (iDAPs) which allow visualization of reports by active ingredient [<a href="#pmed.1004565.ref014" class="usa-link" aria-describedby="pmed.1004565.ref014">14</a>]. Information is provided for various parameters such as: age and sex of the patient, the year of the report, the type of reporter, the severity of the reported ADR and the Medical Dictionary for Regulatory Activities terms for the ADRs reported. The MHRA provide guidance on the appropriate interpretation of the strengths and limitations of this data, which can be found on any given iDAP page (for example <a href="https://info.mhra.gov.uk/drug-analysis-profiles/dap.html?drug=./UK_EXTERNAL/NONCOMBINED/UK_NON_000408008276.zip&amp;agency=MHRA" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://info.mhra.gov.uk/drug-analysis-profiles/dap.html?drug=./UK_EXTERNAL/NONCOMBINED/UK_NON_000408008276.zip&amp;agency=MHRA</a>). Reports are spontaneous and not proven to be related to the linked substance. Reporting of ADRs has consistently increased over time, likely in part due to increased awareness, therefore all analyses are performed with normalised statistics, showing percentage of ADRs by decade, rather than absolute report numbers [<a href="#pmed.1004565.ref015" class="usa-link" aria-describedby="pmed.1004565.ref015">15</a>].</p></section><section id="sec004"><h3 class="pmc_sec_title">Compilation of a master ADR document</h3>
<p>Data was extracted from the MHRA website on May 17, 2024. Files were downloaded using the package rvest 1.0.4 and then compiled into a master doc using the following packages: future 1.33.2, collapse 1.10.6, fst 0.9.8, future.apply 1.11.2, dplyr 1.1.2 and readr 2.1.4. The drug, event and case files supplied as individual csv files on the MHRA website were merged for each ADR report for each drug then combined to make a master file with all publicly available Yellow Card reported ADR information. All programmatic data extraction and data wrangling was performed using R 4.3.0. The code used can be found in the github repository listed here (<a href="https://github.com/whri-phenogenomics/yellow_card_pharmacogenomic_project/tree/main" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://github.com/whri-phenogenomics/yellow_card_pharmacogenomic_project/tree/main</a>).</p></section><section id="sec005"><h3 class="pmc_sec_title">Analysis of the Yellow Card reported ADRS</h3>
<p>Thirty-nine drugs from the PREPARE trial were included in our list of genetically actionable drugs to estimate volume of reported ADRs that could be modified by using PGx information (<a href="#pmed.1004565.s001" class="usa-link">S1 Table</a>) [<a href="#pmed.1004565.ref011" class="usa-link" aria-describedby="pmed.1004565.ref011">11</a>]. We did not include drugs not licensed in the UK (phenprocoumon) or that were deemed unactionable mid-way through the PREPARE trial (clozapine and oxycodone). These PGx medications were grouped to show the number and percentage of ADR reports associated with PGx actionable drug–gene pairs. We therefore limited our assessment of clinically actionable gene–drug pairs to those with impact on ADRs rather than purely efficacy, with stringent evidence criteria, and prospective clinical trial data demonstrating reduction in ADRs with PGx implementation.</p>
<p>To assess the potential impact of mitigating ADRs with PGx for prescribing in primary care, we utilized work from a longitudinal English study [<a href="#pmed.1004565.ref016" class="usa-link" aria-describedby="pmed.1004565.ref016">16</a>]. We applied published data from the Clinical Practice Research Datalink (CPRD) on prescribing prevalence of PGx medications in English primary care to assess the relationship between medication prescribing prevalence and ADR report prevalence from the same drug in the Yellow Card dataset [<a href="#pmed.1004565.ref016" class="usa-link" aria-describedby="pmed.1004565.ref016">16</a>]. This was done to look for any medications or genes which were overrepresented in Yellow Card reports with respect to prescribing prevalence. The data on prevalence of prescribing in the representative CPRD cohort over a 20-year period from 1993 to 2012 was used and compared with Yellow Card ADRs reported for patients in the same age range (30 to 99-years old) during that same time period [<a href="#pmed.1004565.ref016" class="usa-link" aria-describedby="pmed.1004565.ref016">16</a>]. Percentage of ADR reports from the drug of interest were analysed using all ADR reports for our PGx drug list as the denominator to look only at PGx mitigatable Yellow Card ADRs.</p>
<p>Oestrogen reported ADRs were excluded from our PGx mitigatable list to give the most robust conservative estimate of PGx mitigatable ADRs. Oestrogens were not considered as an inclusion criterion in the PREPARE trial. As only specific ADRs would be mitigatable via pharmacodynamic interaction with the <em>F5</em> genetic variant causing factor V Leiden (FVL) hypercoagulability, we opted to exclude them from the list of PGx mitigatable drugs shown above. However, Oestrogens are known to synergistically increase risk of venous thromboembolism (VTE) in patients with FVL leading to PGx mitigatable deep venous thrombosis (DVT) and pulmonary embolism (PE), which can be life threatening complications. We have therefore analysed the number and percentage DVT and PE ADRs for all oestrogens in the Yellow Card reports, as well as the fatality associated with these reports.</p>
<p>Given that the highest speciality for intervention to target mitigatable ADRs appeared to be psychiatry, based on the results of the above analyses, we analysed the ADR reactions to quantify the number, percentage and fatality associated with reported arrythmias for the PGx mitigatable antidepressant and antipsychotic drugs (including citalopram, escitalopram, paroxetine, sertraline, venlafaxine, amitriptyline, clomipramine, doxepin, imipramine, nortriptyline, aripiprazole, haloperidol, pimozide, and zuclopenthixol).</p></section><section id="sec006"><h3 class="pmc_sec_title">Statistical methods</h3>
<p>The percentage of Yellow Card reports made in association with medications linked with pharmacogenomic indications were quantified by decade. The denominator of all Yellow Card reports per decade was used to show the percentage of reported ADRs that may have been intervened on with PGx testing through the history of Yellow Card reporting and account for dynamic shifts in prescribing that occur naturally over the 60-year period of Yellow Card reporting.</p>
<p>This reporting landscape was then analysed by available demographics such as sex and age to look for differences in reporting across PGx actionable drugs and non PGx actionable drugs and noting missing demographic data. Age at the time of ADR is given by the Yellow Card reports in decade bands (i.e., 20 would encompass ages 20- to 29-years old). Reports were stratified by disease area of indication to examine how these examples of potentially PGx mitigatable ADRs are spread across specific specialty prescribers and organ systems.</p>
<p>The 39-drug list described above is a limited subset of known PGx-associated drugs that have DPWG therapeutic recommendations. As a sensitivity analysis we assessed a more extensive CPIC clinically actionable drug list defined as level A and associated with ADR risk, to give a less conservative estimate of potential scale of PGx mitigatable ADRs from the Yellow Card data set.</p>
<p>This study is reported as per the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines (<a href="#pmed.1004565.s012" class="usa-link">S1 STROBE Checklist</a>).</p>
<section id="sec007"><h4 class="pmc_sec_title">Ethics.</h4>
<p>Ethics approval was not required due to the use of public domain data.</p></section></section></section><section id="sec008"><h2 class="pmc_sec_title">Results</h2>
<p>There were 1,345,712 ADR reports over the span of Yellow Card reporting, from 1963 to 2024, attributed to 2,499 different substances. Of these ADR reports, 5% were fatal (<em>n</em> = 61,944) and 65% were serious but non-fatal (<em>n</em> = 874,564) according to the Council for International Organizations of Medical Sciences criteria used by the MHRA. From this dataset, 9% (<em>n</em> = 115,789) of ADR reports were associated with drugs for which ADR risk can be modified based on DPWG pharmacogenomic prescribing guidance as demonstrated by results of the PREPARE trial. These 115,789 drug ADRs, which may have been partly due to gene–drug interactions, involved 12 genes. 75% (<em>n</em> = 87,339) of these ADRs were attributed to medicines which interact with only three pharmacokinetic pharmacogenes (<em>CYP2C19</em>, <em>CYP2D6</em>, <em>SLCO1B1</em>), with an additional 6% (<em>n</em> = 7,215) attributed to medications which interact with a fourth pharmacokinetic pharmacogene (<em>CYP2C9</em>). <a href="#pmed.1004565.g001" class="usa-link">Fig 1</a> shows the percentage of pharmacogene-associated medication ADR reports by decade to correct for changes in prescribing trends over time. The underpinning data is shown in <a href="#pmed.1004565.s002" class="usa-link">S2 Table</a>. The smallest percentage of PGx mitigatable ADRs were reported in the 1970s, where they represented 5% of all Yellow Card reports. The largest was in the 1990s, during which they encompassed 15% of all Yellow Card reports.</p>
<figure class="fig xbox font-sm" id="pmed.1004565.g001"><h3 class="obj_head">Fig 1. Percentage of ADR reports for PGx drugs and associated genes by decade.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11949333_pmed.1004565.g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd0e/11949333/7a4f0add997c/pmed.1004565.g001.jpg" loading="lazy" height="598" width="800" alt="Fig 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/pmed.1004565.g001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The <em>x</em>-axis shows decade of ADR report to reflect changes in prescribing trends over time. The total number of ADRs reported in each decade are as follows: 1960 = 21,341, 1970 = 65,318, 1980 = 132,500, 1990 = 181,754, 2000 = 229,721, 2010 = 396,779 and 2020 = 318,299. ADR, adverse drug reaction; PGx, pharmacogenomics.</p></figcaption></figure><section id="sec009"><h3 class="pmc_sec_title">Pharmacogenes and ADRs</h3>
<p><a href="#pmed.1004565.g002" class="usa-link">Fig 2A</a>–<a href="#pmed.1004565.g002" class="usa-link">2C</a> show the individual medications contributing to the PGx mitigatable reports over time from the top three pharmacogenes of interest. SLCO1B1 is associated with the use of statins, so trends were clearly interpretable over time, but there has been a shift from simvastatin- to atorvastatin-related ADRs over time (<a href="#pmed.1004565.s003" class="usa-link">S3 Table</a>). Trends in Yellow Card ADRs from the CYP2D6 and CYP2C19 metabolised medications (many of which are antidepressants, antipsychotics or analgesics) by decade are shown in <a href="#pmed.1004565.g002" class="usa-link">Fig 2B</a> and <a href="#pmed.1004565.g002" class="usa-link">2C</a> (<a href="#pmed.1004565.s004" class="usa-link">S4</a> and <a href="#pmed.1004565.s005" class="usa-link">S5 Tables</a>). This revealed, for example, that the peak in the 1990s in CYP2D6 drug-related reporting was due to paroxetine. With regards to CYP2C19, tricyclic antidepressant-associated reporting has decreased over time, but serotonin reuptake inhibitors- (SSRIs) associated ADR reports have increased, as prescribing practice has shifted to SSRIs (as seen by progressively lower reports of imipramine and clomipramine ADRs and the emergence of sertraline ADRs after licensing in 1990).</p>
<figure class="fig xbox font-sm" id="pmed.1004565.g002"><h4 class="obj_head">Fig 2. Percentage of adverse drug reactions (ADRs) for pharmacogene-associated medications.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11949333_pmed.1004565.g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd0e/11949333/b58a246beec6/pmed.1004565.g002.jpg" loading="lazy" height="486" width="750" alt="Fig 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/pmed.1004565.g002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>(A)</strong> Percentage of ADRs for <em>SLCO1B1</em>-associated medications. <strong>(B)</strong> Percentage of ADRs for <em>CYP2D6</em>-associated medications. <strong>(C)</strong> Percentage of ADRs for <em>CYP2C19</em>-associated medications. For all graphs, the <em>x</em>-axis shows decade of ADR report to reflect changes in prescribing trends over time, while each contributing drug agent associated with <em>SLCO1B1</em>, <em>CYP2D6</em> and <em>CYP2C19</em> is shown with percentage of total ADR reports per decade on the <em>y</em>-axis. Statin-associated ADR reports start in the 1980s, which is when they emerged as licensed therapeutic agents. ADR, adverse drug reaction.</p></figcaption></figure></section><section id="sec010"><h3 class="pmc_sec_title">Variables associated with PGx mitigable ADRs</h3>
<p><a href="#pmed.1004565.t001" class="usa-link">Table 1</a> shows patient demographics, ADR severity and reporter details for the PGx mitigatable and non PGx mitigable ADRs. Though Yellow Card reports are overall more common in females, there was a higher percentage of males with PGx mitigatable ADRs than non-PGx mitigatable ADRs. Patients who experienced PGx mitigatable ADRs were older and had more severe but non-fatal reactions as compared with patient who experienced a non-PGx mitigatable ADR. PGx mitigatable ADRs were more likely to be reported by patient or carers and more likely to be reported directly to the MHRA rather than reported from industry.</p>
<section class="tw xbox font-sm" id="pmed.1004565.t001"><h4 class="obj_head">Table 1. ADR report numbers and patient demographics stratified by drug PGx status. Sex, age and severity comparison between pharmacogene actionable medicines and non pharmacogene actionable medicines.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead>
<tr>
<th align="left" rowspan="2" colspan="1"></th>
<th align="left" rowspan="1" colspan="1">Total ADRs</th>
<th align="left" rowspan="1" colspan="1">PGx drug ADRs</th>
<th align="left" rowspan="1" colspan="1">Other ADRs</th>
</tr>
<tr>
<th align="left" rowspan="1" colspan="1">(<em>N</em> = 1,345,712)</th>
<th align="left" rowspan="1" colspan="1">(<em>N</em> = 115,789)</th>
<th align="left" rowspan="1" colspan="1">(<em>N</em> = 1,229,923)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Male (%)</strong>
</td>
<td align="left" rowspan="1" colspan="1">38% (<em>n</em> = 512,241)</td>
<td align="left" rowspan="1" colspan="1">40% (<em>n</em> = 45,876)</td>
<td align="left" rowspan="1" colspan="1">38% (<em>n</em> = 466,365)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Female (%)</strong>
</td>
<td align="left" rowspan="1" colspan="1">57% (<em>n</em> = 769,852)</td>
<td align="left" rowspan="1" colspan="1">56% (<em>n</em> = 64,903)</td>
<td align="left" rowspan="1" colspan="1">57% (<em>n</em> = 704,949)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">(Missing data %)</td>
<td align="left" rowspan="1" colspan="1">5% (<em>n</em> = 63,619)</td>
<td align="left" rowspan="1" colspan="1">4% (<em>n</em> = 5,010)</td>
<td align="left" rowspan="1" colspan="1">5% (<em>n</em> = 58,609)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Age (mean</strong> ± <strong>SD)</strong>
</td>
<td align="left" rowspan="1" colspan="1">46.9 (±21.1 years)</td>
<td align="left" rowspan="1" colspan="1">47.1 (±20.5 years)</td>
<td align="left" rowspan="1" colspan="1">46.9 (±21.1 years)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">(Missing data %)</td>
<td align="left" rowspan="1" colspan="1">22% (<em>n</em> = 289,118)</td>
<td align="left" rowspan="1" colspan="1">16% (<em>n</em> = 18,192)</td>
<td align="left" rowspan="1" colspan="1">22% (<em>n</em> = 270,926)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Severity</strong>
</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Nonserious (%)</strong>
</td>
<td align="left" rowspan="1" colspan="1">30% (<em>n</em> = 409,188)</td>
<td align="left" rowspan="1" colspan="1">27% (<em>n</em> = 30,678)</td>
<td align="left" rowspan="1" colspan="1">31% (<em>n</em> = 378,510)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Serious (%)</strong>
</td>
<td align="left" rowspan="1" colspan="1">65% (<em>n</em> = 874,564)</td>
<td align="left" rowspan="1" colspan="1">69% (<em>n</em> = 80,062)</td>
<td align="left" rowspan="1" colspan="1">64% (<em>n</em> = 794,502)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Fatal (%)</strong>
</td>
<td align="left" rowspan="1" colspan="1">5% (<em>n</em> = 61,944)</td>
<td align="left" rowspan="1" colspan="1">4% (<em>n</em> = 5,049)</td>
<td align="left" rowspan="1" colspan="1">5% (<em>n</em> = 56,895)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">(Missing data %)</td>
<td align="left" rowspan="1" colspan="1">0% (<em>n</em> = 16)</td>
<td align="left" rowspan="1" colspan="1">0% (<em>n</em> = 0)</td>
<td align="left" rowspan="1" colspan="1">0% (<em>n</em> = 16)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>HCP reporter (%)</strong>
</td>
<td align="left" rowspan="1" colspan="1">80% (<em>n</em> = 1,082,961)</td>
<td align="left" rowspan="1" colspan="1">80% (<em>n</em> = 93,082)</td>
<td align="left" rowspan="1" colspan="1">80% (<em>n</em> = 989,879)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Patient/Carer (%)</strong>
</td>
<td align="left" rowspan="1" colspan="1">16% (<em>n</em> = 213,597)</td>
<td align="left" rowspan="1" colspan="1">17% (<em>n</em> = 19,247)</td>
<td align="left" rowspan="1" colspan="1">16% (<em>n</em> = 194,350)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Both %</strong>
</td>
<td align="left" rowspan="1" colspan="1">4% (<em>n</em> = 49,154)</td>
<td align="left" rowspan="1" colspan="1">3% (3,460)</td>
<td align="left" rowspan="1" colspan="1">4% (<em>n</em> = 45,694)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Direct reports (%)</strong>
</td>
<td align="left" rowspan="1" colspan="1">67% (<em>n</em> = 903,325)</td>
<td align="left" rowspan="1" colspan="1">75% (<em>n</em> = 86,665)</td>
<td align="left" rowspan="1" colspan="1">66.4% (<em>n</em> = 816,660)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Indirect reports (%)</strong>
</td>
<td align="left" rowspan="1" colspan="1">33% (<em>n</em> = 442,387)</td>
<td align="left" rowspan="1" colspan="1">25% (<em>n</em> = 29,124)</td>
<td align="left" rowspan="1" colspan="1">33.6% (<em>n</em> = 413,263)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">(Missing data %)</td>
<td align="left" rowspan="1" colspan="1">0% (<em>n</em> = 0)</td>
<td align="left" rowspan="1" colspan="1">0% (<em>n</em> = 0)</td>
<td align="left" rowspan="1" colspan="1">0% (<em>n</em> = 0)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pmed.1004565.t001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="t001fn001"><p>ADR, adverse drug reaction; PGx, Pharmacogenomic; SD, Standard deviation; HCP, Healthcare professional. Indirect reports come from industry as compared with direct reports to the MHRA. There were no counts of missing data from Direct vs Indirect reporter category.</p></div></div></section></section><section id="sec011"><h3 class="pmc_sec_title">Specific drugs and ADRs</h3>
<p>Organ based speciality prescribers for PGx mitigatable ADRs are shown in <a href="#pmed.1004565.g003" class="usa-link">Fig 3</a> (<a href="#pmed.1004565.s006" class="usa-link">S6 Table</a>). Over 47% of all the PGx mitigatable ADRs identified were attributed to psychiatric medications (<em>n</em> = 54,846). This was followed by cardiovascular medications, accounting for 24% (<em>n</em> = 28,279).</p>
<figure class="fig xbox font-sm" id="pmed.1004565.g003"><h4 class="obj_head">Fig 3. Percentage of PGx mitigatable ADRs by prescriber specialty.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11949333_pmed.1004565.g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd0e/11949333/2318616fa998/pmed.1004565.g003.jpg" loading="lazy" height="514" width="800" alt="Fig 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/pmed.1004565.g003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The breakdown of prescribing indication by specialty can be found in <a href="#pmed.1004565.s001" class="usa-link">S1 Table</a>. The following were classified as Rheumatology medications: azathioprine, mercaptopurine. The following were classified as Psychiatry medications: citalopram, escitalopram, paroxetine, sertraline, venlafaxine, amitriptyline, clomipramine, doxepin, imipramine, nortriptyline, carbamazepine, aripiprazole, haloperidol, pimozide, zuclopenthixol, atomoxetine. The following were classified as Oncology medications: capecitabine, 5-fluorouracil, irinotecan, tamoxifen, tegafur, thioguanine, mercaptopurine. The following were classified as Neurology medications: phenytoin, carbamazepine, azathioprine, mercaptopurine. The following were classified as Infectious Disease medications: efavirenz, flucloxacillin, voriconazole. The following were classified as Gastroenterology medications: azathioprine, mercaptopurine. The following were classified as Cross Speciality medications: codeine, tramadol, tacrolimus, azathioprine, mercaptopurine. The following were classified as cardiovascular medications: flecainide, propafenone, metoprolol, atorvastatin, simvastatin, acenocoumarol, clopidogrel, warfarin. *Cross Specialty medications include analgesics and immunosuppressants prescribed by multiple different specialties for multiple different organ indications. ADR, adverse drug reaction; PGx, pharmacogenomics.</p></figcaption></figure><p>A comparison of prescribing prevalence from CPRD data with proportion of mitigatable ADRs associated with PGx drugs is shown in <a href="#pmed.1004565.g004" class="usa-link">Fig 4</a> (<a href="#pmed.1004565.s007" class="usa-link">S7 Table</a>). It is notable that the majority of the PGx drugs with disproportionately high Yellow Card ADR reporting as compared with prescribing prevalence are psychiatric drugs.</p>
<figure class="fig xbox font-sm" id="pmed.1004565.g004"><h4 class="obj_head">Fig 4. Proportion of ADRs per drug compared with prescribing prevalence.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11949333_pmed.1004565.g004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd0e/11949333/185563cc4ecd/pmed.1004565.g004.jpg" loading="lazy" height="292" width="750" alt="Fig 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/pmed.1004565.g004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The <em>x</em>-axis denotes prescribing prevalence (% of the population prescribed the drug in a 20-year period (1993–2012) based on the published CPRD data from Kimpton and colleagues [<a href="#pmed.1004565.ref016" class="usa-link" aria-describedby="pmed.1004565.ref016">16</a>]). The <em>y</em>-axis shows the percentage of all PGx mitigatable ADRs represented by each drug during the same 20-year period. Those medicines which extend over the blue line are overrepresented in Yellow Card ADR volume as compared with prescribing prevalence. ADR, adverse drug reaction.</p></figcaption></figure><p>The analysis of Oestrogen associated DVT and PE reports, which may be mitigated by avoiding these drugs in <em>F5</em> variant carriers, revealed that 3,917 DVTs or PEs were reported in association with use of different oestrogens. Fifty-two percent of these were DVTs and 48% were PEs. Most (73%) of these VTE reports were associated with ethinylestradiol and all of the reported VTE events were classed as either serious (86%) or fatal events (14%) (<a href="#pmed.1004565.s008" class="usa-link">S8 Table</a>).</p>
<p>The analysis of antidepressant- and antipsychotic-associated arrhythmia ADRs from PGx modifiable drugs revealed only 3% of the ADRs were cardiac arrhythmias (<em>n</em> = 1515), and fatal cardiac arrhythmias were uncommon consequences, comprising only 0.4% of these ADRs (<em>n</em> = 172 of <em>n</em> = 48,315 total ADRs). Of these cardiac arrhythmias ADRs 88% were severe and 11% were fatal, accounting for 10% of all fatalities associated with these drugs (<a href="#pmed.1004565.s009" class="usa-link">S9 Table</a>). Most of the antidepressant- and antipsychotic-associated ADRs from PGx modifiable drugs were severe or fatal (67% severe, 3% fatal) and are described in <a href="#pmed.1004565.s010" class="usa-link">S10 Table</a>.</p>
<p>The more extensive CPIC clinically actionable drug list (level A and associated with ADR risk) (64 drugs, <a href="#pmed.1004565.s011" class="usa-link">S11 Table</a>) suggests that 10.9% of ADRs may be mitigated (as compared with the 9% we found for the more stringent list validated by prospective clinical trial evidence).</p></section></section><section id="sec012"><h2 class="pmc_sec_title">Discussion</h2>
<p>We have reported a national pharmacovigilance programme-based analysis of PGx drug-associated ADR reports at scale (<a href="#pmed.1004565.g005" class="usa-link">Fig 5</a>). We found that, among a large cohort of an excess of a million spontaneously reported ADRs during a span of 60 years, 9% were potentially mitigable by a pharmacogenomic approach. The prevalence of PGx mitigatable ADRs associated with these drugs has varied substantially by decade with peaks in reporting for single agents, most notably paroxetine, which contributed to a peak in PGx mitigatable ADRs in the 1990s.</p>
<figure class="fig xbox font-sm" id="pmed.1004565.g005"><h3 class="obj_head">Fig 5. Study methods and results overview.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11949333_pmed.1004565.g005.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd0e/11949333/9f80100f229d/pmed.1004565.g005.jpg" loading="lazy" height="527" width="763" alt="Fig 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/pmed.1004565.g005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>PGx, pharmacogenomics; ADR, adverse drug reaction.</p></figcaption></figure><p>Kimpton and colleagues found that drug interactions with only three pharmacogenes (<em>CYP2D6</em>, <em>CYP2C19</em> and <em>SLCO1B1</em>) account for the vast majority of PGx interactions in primary care prescribing (&gt;95%) in an English setting [<a href="#pmed.1004565.ref016" class="usa-link" aria-describedby="pmed.1004565.ref016">16</a>]. Importantly, all of these genes impact on drug safety via pharmacokinetic pathways impacting the metabolism and excretion of the associated medications. Here, we find that those same limited three pharmacokinetic genes could potentially account for three in every four PGx mitigatable ADRs represented by the Yellow Card reports in the last five decades. This can inform pilot PGx implementation in direct healthcare by prioritising these genes. It is important to note that these are polymorphic genes that impact on the metabolism of many medications. This study characterised the most conservative estimate of PGx mitigatable harms, but we have also extrapolated the potential mitigatable harms if extended pharmacogenomic panels are proven prospectively to mitigate ADRs. As defined by the CPIC implementable list of drug–gene pairs this may extend the PGx mitigatable ADRs to 11%, an increment of 2% higher than our estimates presented here.</p>
<p>While we excluded oestrogens associated with increased risk of VTE in FVL from our PGx mitigatable group to give a conservative estimate, it is informative to see that nearly 4,000 VTE events have been reported, mostly associated with one formulation of oestrogen, ethinylestradiol. While it is unclear how many of these events may have been prevented using prospective PGx, 100% of these were serious or fatal, thus giving a powerful impetus to trial PGx implementation.</p>
<p>Trial data shows that of these potentially PGx mitigatable ADRs we might expect a 30% reduction with the use of prospective genotyping to inform prescribing [<a href="#pmed.1004565.ref011" class="usa-link" aria-describedby="pmed.1004565.ref011">11</a>]. If we extrapolate to Yellow Card data, then we can expect 34,737 reported ADRs may have been avoided with the limited 12-gene pharmacogenomic panel employed by the PREPARE trial [<a href="#pmed.1004565.ref011" class="usa-link" aria-describedby="pmed.1004565.ref011">11</a>]. The fact that the PGx mitigatable ADRs were more likely than non-PGx mitigatable ADRs to be severe has important healthcare cost implications. However, the PREPARE trial recruited based on indication for an index drug, included only 12 weeks of follow up, and actively asked participants about potential ADRs then adjudicated reactions to determine likely causal relationship with the medication. Therefore, this extrapolation is interesting, but may not be representative of the impact real world PGx prescribing would have on Yellow Card reporting of ADRs prospectively.</p>
<p>CYP2D6 and CYP2C19 are known to show large differences in prevalence of predicted extreme metabolizer types (poor metabolizers or ultrarapid metabolizers) across diverse ancestry groups due to varying prevalence of common genetic variants [<a href="#pmed.1004565.ref017" class="usa-link" aria-describedby="pmed.1004565.ref017">17</a>–<a href="#pmed.1004565.ref019" class="usa-link" aria-describedby="pmed.1004565.ref019">19</a>]. It is unfortunate that ancestry data was not available for these Yellow Card reports; however, based on what is known about polymorphism frequencies in these genes, that ADRs associated with a typical metabolizer types of associated drugs will be more frequent in under-represented African and Asian ancestry groups (<a href="#pmed.1004565.t002" class="usa-link">Table 2</a>) [<a href="#pmed.1004565.ref002" class="usa-link" aria-describedby="pmed.1004565.ref002">2</a>,<a href="#pmed.1004565.ref017" class="usa-link" aria-describedby="pmed.1004565.ref017">17</a>,<a href="#pmed.1004565.ref018" class="usa-link" aria-describedby="pmed.1004565.ref018">18</a>]. Therefore, piloting PGx with these few selective genes would not only capture 75% of all mitigatable ADRs but would also disproportionately benefit these populations therefore targeting existing health inequalities.</p>
<section class="tw xbox font-sm" id="pmed.1004565.t002"><h3 class="obj_head">Table 2. A typical metaboliser prevalence for CYP2D6 and CYP2C19 across diverse ancestry groups. These are genetically predicted based on data published by PharmGKB and CPIC. We have defined atypical metabolisers as the following: poor (activity score 0 for 2D6), intermediate (activity score &lt;1 for 2D6), and ultrarapid metabolisers (activity score &gt;2 for 2D6).</h3>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" rowspan="1" colspan="1">Biogeographical groups</th>
<th align="left" rowspan="1" colspan="1">CYP2D6 atypical metabolisers</th>
<th align="left" rowspan="1" colspan="1">CYP2C19 atypical metabolisers</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>African American/Afro-Caribbean</strong>
</td>
<td align="left" rowspan="1" colspan="1">22%</td>
<td align="left" rowspan="1" colspan="1">40%</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>American</strong>
</td>
<td align="left" rowspan="1" colspan="1">10%</td>
<td align="left" rowspan="1" colspan="1">24%</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Central/South Asian</strong>
</td>
<td align="left" rowspan="1" colspan="1">15%</td>
<td align="left" rowspan="1" colspan="1">52%</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>East Asian</strong>
</td>
<td align="left" rowspan="1" colspan="1">34%</td>
<td align="left" rowspan="1" colspan="1">59%</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>European</strong>
</td>
<td align="left" rowspan="1" colspan="1">19%</td>
<td align="left" rowspan="1" colspan="1">33%</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Latino</strong>
</td>
<td align="left" rowspan="1" colspan="1">14%</td>
<td align="left" rowspan="1" colspan="1">23%</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Near Eastern</strong>
</td>
<td align="left" rowspan="1" colspan="1">28%</td>
<td align="left" rowspan="1" colspan="1">29%</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Oceanian</strong>
</td>
<td align="left" rowspan="1" colspan="1">22%</td>
<td align="left" rowspan="1" colspan="1">94%</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Sub-Saharan African</strong>
</td>
<td align="left" rowspan="1" colspan="1">25%</td>
<td align="left" rowspan="1" colspan="1">37%</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pmed.1004565.t002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Our analysis of national pharmacovigilance reporting at scale shows that the greatest potential area of intervention by specialty to mitigate Yellow Card reported ADRs in the UK may be within psychiatry. Psychiatric medication associated ADRs were the highest prevalence across organ systems (accounting for roughly half of all PGx mitigatable ADRs) and among the most overrepresented ADRs with respect to prescribing prevalence. This is synergistic evidence with the recently published secondary data from the PREPARE trial, which showed that those psychiatric patients with an actionable genotype in the intervention arm had a 34% reduction in ADRs, 41% reduction in hospitalisations and 41% lower readmission rates in addition to shorter hospital stays [<a href="#pmed.1004565.ref020" class="usa-link" aria-describedby="pmed.1004565.ref020">20</a>]. Although PGx mitigatable Yellow Card ADRs associated with psychiatric medication had a low prevalence of arrhythmias there were a substantial number of events reported, 1515, and 99% of these were either severe or fatal. Yet, arrhythmias represented only 10% of fatal ADR reports associated with these agents.</p>
<p>There are some limitations to the data presented. The voluntary nature of Yellow Card ADR reporting is likely to lead to potential biases and broadly acknowledged under-reporting. Milder and more predictable ADRs may be less likely to be spontaneously reported to the MHRA compared to atypical and more severe ADRs. The quality of the data may vary, with some reports containing incomplete information, and these reports have not been independently adjudicated. As catalogued in <a href="#pmed.1004565.t001" class="usa-link">Table 1</a>, there is a high level of missingness in some of the demographic data such as age. Age is supplied by the MHRA in this data rounded to the lowest decade as described in the methods section. Furthermore, information on medical comorbidities and other drugs taken at the time of the ADR were not available. However, the scale and duration make this dataset the most comprehensive nationally. Therefore, it is a valuable resource to examine the scope of potentially PGx mitigatable reported ADRs. Pharmacovigilance programmes, such as Yellow Card reporting, VigiBase and the FDA’s FAERS continue to be used because they have proven value in detecting safety signals despite limitations in the completeness and quality of ADR reports submitted.</p>
<p>Although the CPRD prescribing may not be representative of prescribing patterns in different subgroups it is likely that any bias would be toward healthier groups who engage in research. For example, the percentage of British South Asian participants from the Genes &amp; Health cohort prescribed the antidepressants investigated is known to be higher than the CPRD data shows [<a href="#pmed.1004565.ref021" class="usa-link" aria-describedby="pmed.1004565.ref021">21</a>]. Therefore, the CRPD data would seem to provide a conservative and robust population level low-end estimate.</p>
<p>In conclusion, Yellow Card reports from the UK’s pharmacovigilance programme depict a national experience of reported ADRs since 1963. Our findings suggest that a limited panel of three pharmacogenes could potentially pre-emptively identify most of those at risk of ADRs and avoid significant patient harm and hospitalisation. Based on our findings, Psychiatry may be the single highest impact specialty to pilot PGx in the UK to reduce ADRs and associated morbidity, mortality and costs. These findings are based on the analysis of the Yellow Card dataset described and may not represent all ADRs from a generalised patient population.</p></section><section id="sec013"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="pmed.1004565.s001"><div class="caption p">
<span>S1 Table. List of pharmacogenomic drugs, their associated gene(s) and prescriber category.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11949333/bin/pmed.1004565.s001.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pmed.1004565.s001.xlsx</a><sup> (9.9KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pmed.1004565.s002"><div class="caption p">
<span>S2 Table. Number and percentage of adverse drug reactions associated with pharmacogenomic drugs stratified by decade.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11949333/bin/pmed.1004565.s002.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pmed.1004565.s002.xlsx</a><sup> (10.9KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pmed.1004565.s003"><div class="caption p">
<span>S3 Table. Number and percentage of adverse drug reaction reports associated with PREPARE drugs that have a pharmacogneomic indication for the gene SLCO1B1 stratified by decade.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11949333/bin/pmed.1004565.s003.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pmed.1004565.s003.xlsx</a><sup> (8.8KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pmed.1004565.s004"><div class="caption p">
<span>S4 Table. Number and percentage of adverse drug reaction reports associated with PREPARE drugs that have a pharmacogneomic indication for the gene CYP2D6 stratified by decade.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11949333/bin/pmed.1004565.s004.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pmed.1004565.s004.xlsx</a><sup> (12.3KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pmed.1004565.s005"><div class="caption p">
<span>S5 Table. Number and percentage of adverse drug reaction reports associated with PREPARE drugs that have a pharmacogneomic indication for the gene CYP2C19 stratified by decade.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11949333/bin/pmed.1004565.s005.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pmed.1004565.s005.xlsx</a><sup> (10KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pmed.1004565.s006"><div class="caption p">
<span>S6 Table. Number and percenateg of PGx assoicated adverse drug reactions stratified by prescriber category.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11949333/bin/pmed.1004565.s006.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pmed.1004565.s006.xlsx</a><sup> (10.8KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pmed.1004565.s007"><div class="caption p">
<span>S7 Table. PGx (number and percentage) associated adverse drug reactions and the prescribing prevalence (number and percentage) over a 20-year period (1993–2013).</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11949333/bin/pmed.1004565.s007.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pmed.1004565.s007.xlsx</a><sup> (10.4KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pmed.1004565.s008"><div class="caption p">
<span>S8 Table. Number and percentage of pharmacogenomic mitigatable adverse drug reactions of oestrogen drugs.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11949333/bin/pmed.1004565.s008.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pmed.1004565.s008.xlsx</a><sup> (10KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pmed.1004565.s009"><div class="caption p">
<span>S9 Table. Psychiatric pharmacogenomic drugs stratified by type of adverse drug reaction (cardiac arrhythmia or other) and the level of seriousness.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11949333/bin/pmed.1004565.s009.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pmed.1004565.s009.xlsx</a><sup> (13KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pmed.1004565.s010"><div class="caption p">
<span>S10 Table. Psychiatric pharmacogenomic adverse drug reactions stratified by level of seriousness.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11949333/bin/pmed.1004565.s010.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pmed.1004565.s010.xlsx</a><sup> (10.2KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pmed.1004565.s011"><div class="caption p">
<span>S11 Table. Clinical Pharmacogenetics Implementation Consortium list of clinically actionable drugs with a pharmacogenomic indication and their associated genes.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11949333/bin/pmed.1004565.s011.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pmed.1004565.s011.xlsx</a><sup> (10.6KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pmed.1004565.s012"><div class="caption p">
<span>S11. STROBE checklist.</span><p>(DOCX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11949333/bin/pmed.1004565.s012.docx" data-ga-action="click_feat_suppl" class="usa-link">pmed.1004565.s012.docx</a><sup> (32.8KB, docx) </sup>
</div></div></section></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>ADRs</dt>
<dd><p>adverse drug reactions</p></dd>
<dt>CPIC</dt>
<dd><p>Clinical Pharmacogenetics Implementation Consortium</p></dd>
<dt>CPRD</dt>
<dd><p>Clinical Practice Research Datalink</p></dd>
<dt>DPWG</dt>
<dd><p>Dutch Pharmacogenetics Working Group</p></dd>
<dt>DVT</dt>
<dd><p>deep venous thrombosis</p></dd>
<dt>FVL</dt>
<dd><p>factor V Leiden</p></dd>
<dt>iDAPs</dt>
<dd><p>interactive drug analysis profiles</p></dd>
<dt>MHRA</dt>
<dd><p>Medicines and Healthcare products Regulatory Agency</p></dd>
<dt>PE</dt>
<dd><p>pulmonary embolism</p></dd>
<dt>PGx</dt>
<dd><p>pharmacogenomics</p></dd>
<dt>SSRIs</dt>
<dd><p>serotonin reuptake inhibitors</p></dd>
<dt>STROBE</dt>
<dd><p>Strengthening the Reporting of Observational Studies in Epidemiology</p></dd>
<dt>VTE</dt>
<dd><p>venous thromboembolism</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Data Availability</h2>
<p>Data and code: Data used is openly available from the MHRA (<a href="https://yellowcard.mhra.gov.uk/idaps" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://yellowcard.mhra.gov.uk/idaps</a>). We have made available the code we used to compile the MHRA published csvs (<a href="https://github.com/whri-phenogenomics/yellow_card_pharmacogenomic_project/tree/main" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://github.com/whri-phenogenomics/yellow_card_pharmacogenomic_project/tree/main</a>)</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>EFM was funded by Barts Charity and an NIHR Clinical Lectureship. MM was funded by the University of Glasgow’s Life Sciences Vacation Scholarship. This work forms part of the funded research portfolio of the NIHR Barts Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="pmed.1004565.ref001">
<span class="label">1.</span><cite>Pirmohamed M. Pharmacogenomics: current status and future perspectives. Nat Rev Genet. 2023;24(6):350–62. doi: 10.1038/s41576-022-00572-8

</cite> [<a href="https://doi.org/10.1038/s41576-022-00572-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36707729/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Genet&amp;title=Pharmacogenomics:%20current%20status%20and%20future%20perspectives&amp;author=M%20Pirmohamed&amp;volume=24&amp;issue=6&amp;publication_year=2023&amp;pages=350-62&amp;pmid=36707729&amp;doi=10.1038/s41576-022-00572-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pmed.1004565.ref002">
<span class="label">2.</span><cite>McInnes G, Lavertu A, Sangkuhl K, Klein TE, Whirl-Carrillo M, Altman RB. Pharmacogenetics at scale: an analysis of the UK Biobank. Clin Pharmacol Ther. 2021;109(6):1528–37. doi: 10.1002/cpt.2122

</cite> [<a href="https://doi.org/10.1002/cpt.2122" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8144239/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33237584/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Pharmacol%20Ther&amp;title=Pharmacogenetics%20at%20scale:%20an%20analysis%20of%20the%20UK%20Biobank&amp;author=G%20McInnes&amp;author=A%20Lavertu&amp;author=K%20Sangkuhl&amp;author=TE%20Klein&amp;author=M%20Whirl-Carrillo&amp;volume=109&amp;issue=6&amp;publication_year=2021&amp;pages=1528-37&amp;pmid=33237584&amp;doi=10.1002/cpt.2122&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pmed.1004565.ref003">
<span class="label">3.</span><cite>Budnitz DS, Shehab N, Lovegrove MC, Geller AI, Lind JN, Pollock DA. US Emergency Department visits attributed to medication harms, 2017-2019. JAMA. 2021;326(13):1299–309. doi: 10.1001/jama.2021.13844

</cite> [<a href="https://doi.org/10.1001/jama.2021.13844" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8493432/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34609453/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=US%20Emergency%20Department%20visits%20attributed%20to%20medication%20harms,%202017-2019&amp;author=DS%20Budnitz&amp;author=N%20Shehab&amp;author=MC%20Lovegrove&amp;author=AI%20Geller&amp;author=JN%20Lind&amp;volume=326&amp;issue=13&amp;publication_year=2021&amp;pages=1299-309&amp;pmid=34609453&amp;doi=10.1001/jama.2021.13844&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pmed.1004565.ref004">
<span class="label">4.</span><cite>Osanlou R, Walker L, Hughes DA, Burnside G, Pirmohamed M. Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions. BMJ Open. 2022;12(7):e055551. doi: 10.1136/bmjopen-2021-055551

</cite> [<a href="https://doi.org/10.1136/bmjopen-2021-055551" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9255409/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35788071/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ%20Open&amp;title=Adverse%20drug%20reactions,%20multimorbidity%20and%20polypharmacy:%20a%20prospective%20analysis%20of%201%20month%20of%20medical%20admissions&amp;author=R%20Osanlou&amp;author=L%20Walker&amp;author=DA%20Hughes&amp;author=G%20Burnside&amp;author=M%20Pirmohamed&amp;volume=12&amp;issue=7&amp;publication_year=2022&amp;pages=e055551&amp;pmid=35788071&amp;doi=10.1136/bmjopen-2021-055551&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pmed.1004565.ref005">
<span class="label">5.</span><cite>Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15–9. doi: 10.1136/bmj.329.7456.15

</cite> [<a href="https://doi.org/10.1136/bmj.329.7456.15" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC443443/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15231615/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=Adverse%20drug%20reactions%20as%20cause%20of%20admission%20to%20hospital:%20prospective%20analysis%20of%2018%20820%20patients&amp;author=M%20Pirmohamed&amp;author=S%20James&amp;author=S%20Meakin&amp;author=C%20Green&amp;author=AK%20Scott&amp;volume=329&amp;issue=7456&amp;publication_year=2004&amp;pages=15-9&amp;pmid=15231615&amp;doi=10.1136/bmj.329.7456.15&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pmed.1004565.ref006">
<span class="label">6.</span><cite>Office for National Statistics. Living longer: how our population is changing and why it matters; 2018.  [cited 30 Nov 2023]. Available from: <a href="https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/ageing/articles/livinglongerhowourpopulationischangingandwhyitmatters/2018-08-13#how-is-the-uk-population-changing" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/ageing/articles/livinglongerhowourpopulationischangingandwhyitmatters/2018-08-13#how-is-the-uk-population-changing</a></cite> [<a href="https://scholar.google.com/scholar_lookup?Office%20for%20National%20Statistics.%20Living%20longer:%20how%20our%20population%20is%20changing%20and%20why%20it%20matters;%202018.%20%5Bcited%2030%20Nov%202023%5D.%20Available%20from:%20https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/ageing/articles/livinglongerhowourpopulationischangingandwhyitmatters/2018-08-13#how-is-the-uk-population-changing" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pmed.1004565.ref007">
<span class="label">7.</span><cite>Department of Health &amp; Social Care. Good for you, good for us, good for everybody: A plan to reduce overprescribing to make patient care better and safer, support the NHS, and reduce carbon emissions. Sep
2021.  [cited 10 Feb 2025]. Available from: <a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1019475/good-for-you-good-for-us-good-for-everybody.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1019475/good-for-you-good-for-us-good-for-everybody.pdf</a></cite> [<a href="https://scholar.google.com/scholar_lookup?Department%20of%20Health%20&amp;%20Social%20Care.%20Good%20for%20you,%20good%20for%20us,%20good%20for%20everybody:%20A%20plan%20to%20reduce%20overprescribing%20to%20make%20patient%20care%20better%20and%20safer,%20support%20the%20NHS,%20and%20reduce%20carbon%20emissions.%20Sep%202021.%20%5Bcited%2010%20Feb%202025%5D.%20Available%20from:%20https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1019475/good-for-you-good-for-us-good-for-everybody.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pmed.1004565.ref008">
<span class="label">8.</span><cite>Kingston A, Robinson L, Booth H, Knapp M, Jagger C, MODEM project. Projections of multi-morbidity in the older population in England to 2035: estimates from the Population Ageing and Care Simulation (PACSim) model. Age Ageing. 2018;47(3):374–80. doi: 10.1093/ageing/afx201

</cite> [<a href="https://doi.org/10.1093/ageing/afx201" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5920286/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29370339/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Age%20Ageing&amp;title=Projections%20of%20multi-morbidity%20in%20the%20older%20population%20in%20England%20to%202035:%20estimates%20from%20the%20Population%20Ageing%20and%20Care%20Simulation%20(PACSim)%20model&amp;author=A%20Kingston&amp;author=L%20Robinson&amp;author=H%20Booth&amp;author=M%20Knapp&amp;author=C%20Jagger&amp;volume=47&amp;issue=3&amp;publication_year=2018&amp;pages=374-80&amp;pmid=29370339&amp;doi=10.1093/ageing/afx201&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pmed.1004565.ref009">
<span class="label">9.</span><cite>Official statistics N statistics. Prescriptions dispensed in the community: prescriptions dispensed in the community – statistics for England, 2006-2016. NHS Digital; 2017.  [cited 30 Nov 2023]. Available from: <a href="https://digital.nhs.uk/data-and-information/publications/statistical/prescriptions-dispensed-in-the-community/prescriptions-dispensed-in-the-community-statistics-for-england-2006-2016-pas" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://digital.nhs.uk/data-and-information/publications/statistical/prescriptions-dispensed-in-the-community/prescriptions-dispensed-in-the-community-statistics-for-england-2006-2016-pas</a></cite> [<a href="https://scholar.google.com/scholar_lookup?Official%20statistics%20N%20statistics.%20Prescriptions%20dispensed%20in%20the%20community:%20prescriptions%20dispensed%20in%20the%20community%20%E2%80%93%20statistics%20for%20England,%202006-2016.%20NHS%20Digital;%202017.%20%5Bcited%2030%20Nov%202023%5D.%20Available%20from:%20https://digital.nhs.uk/data-and-information/publications/statistical/prescriptions-dispensed-in-the-community/prescriptions-dispensed-in-the-community-statistics-for-england-2006-2016-pas" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pmed.1004565.ref010">
<span class="label">10.</span><cite>NHS Digital. Prescriptions dispensed in the community—statistics for England, 2007-2017; 2018.  [cited 30 Nov 2023]. Available from: <a href="https://digital.nhs.uk/data-and-information/publications/statistical/prescriptions-dispensed-in-the-community/prescriptions-dispensed-in-the-community-england---2007---2017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://digital.nhs.uk/data-and-information/publications/statistical/prescriptions-dispensed-in-the-community/prescriptions-dispensed-in-the-community-england---2007---2017</a></cite> [<a href="https://scholar.google.com/scholar_lookup?NHS%20Digital.%20Prescriptions%20dispensed%20in%20the%20community%E2%80%94statistics%20for%20England,%202007-2017;%202018.%20%5Bcited%2030%20Nov%202023%5D.%20Available%20from:%20https://digital.nhs.uk/data-and-information/publications/statistical/prescriptions-dispensed-in-the-community/prescriptions-dispensed-in-the-community-england---2007---2017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pmed.1004565.ref011">
<span class="label">11.</span><cite>Swen JJ, van der Wouden CH, Manson LE, Abdullah-Koolmees H, Blagec K, Blagus T, et al. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study. Lancet. 2023;401(10374):347–56. doi: 10.1016/S0140-6736(22)01841-4

</cite> [<a href="https://doi.org/10.1016/S0140-6736(22)01841-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36739136/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=A%2012-gene%20pharmacogenetic%20panel%20to%20prevent%20adverse%20drug%20reactions:%20an%20open-label,%20multicentre,%20controlled,%20cluster-randomised%20crossover%20implementation%20study&amp;author=JJ%20Swen&amp;author=CH%20van%20der%20Wouden&amp;author=LE%20Manson&amp;author=H%20Abdullah-Koolmees&amp;author=K%20Blagec&amp;volume=401&amp;issue=10374&amp;publication_year=2023&amp;pages=347-56&amp;pmid=36739136&amp;doi=10.1016/S0140-6736(22)01841-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pmed.1004565.ref012">
<span class="label">12.</span><cite>Relling MV, Klein TE. CPIC: clinical Pharmacogenetics Implementation Consortium of the pharmacogenomics research network. Clin Pharmacol Ther. 2011;89(3):464–7. doi: 10.1038/clpt.2010.279

</cite> [<a href="https://doi.org/10.1038/clpt.2010.279" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3098762/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21270786/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Pharmacol%20Ther&amp;title=CPIC:%20clinical%20Pharmacogenetics%20Implementation%20Consortium%20of%20the%20pharmacogenomics%20research%20network&amp;author=MV%20Relling&amp;author=TE%20Klein&amp;volume=89&amp;issue=3&amp;publication_year=2011&amp;pages=464-7&amp;pmid=21270786&amp;doi=10.1038/clpt.2010.279&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pmed.1004565.ref013">
<span class="label">13.</span><cite>Dutch Pharmacogenetic Working Group of the Royal Dutch Pharmacists Association. [cited 13 Aug 2020]. Available from: <a href="https://www.knmp.nl/dossiers/farmacogenetica" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.knmp.nl/dossiers/farmacogenetica</a></cite> [<a href="https://scholar.google.com/scholar_lookup?Dutch%20Pharmacogenetic%20Working%20Group%20of%20the%20Royal%20Dutch%20Pharmacists%20Association.%20%5Bcited%2013%20Aug%202020%5D.%20Available%20from:%20https://www.knmp.nl/dossiers/farmacogenetica" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pmed.1004565.ref014">
<span class="label">14.</span><cite>Medicines &amp; Healthcare products Regulatory Agency. Yellow Card: Making medicines and medical devices safer: interactive Drug Analysis Profiles (iDAPs). [cited 10 Feb 2025]. Available from: <a href="https://yellowcard.mhra.gov.uk/idaps" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://yellowcard.mhra.gov.uk/idaps</a></cite> [<a href="https://scholar.google.com/scholar_lookup?Medicines%20&amp;%20Healthcare%20products%20Regulatory%20Agency.%20Yellow%20Card:%20Making%20medicines%20and%20medical%20devices%20safer:%20interactive%20Drug%20Analysis%20Profiles%20(iDAPs).%20%5Bcited%2010%20Feb%202025%5D.%20Available%20from:%20https://yellowcard.mhra.gov.uk/idaps" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pmed.1004565.ref015">
<span class="label">15.</span><cite>Report of an independent review of access to the Yellow Card scheme. 2004. 
Apr. Available from: <a href="https://sante.gouv.fr/IMG/pdf/Report_of_an_Independent_Review_of_Access_to_the_Yellow_Card_Scheme.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://sante.gouv.fr/IMG/pdf/Report_of_an_Independent_Review_of_Access_to_the_Yellow_Card_Scheme.pdf</a></cite> [<a href="https://scholar.google.com/scholar_lookup?Report%20of%20an%20independent%20review%20of%20access%20to%20the%20Yellow%20Card%20scheme.%202004.%20Apr.%20Available%20from:%20https://sante.gouv.fr/IMG/pdf/Report_of_an_Independent_Review_of_Access_to_the_Yellow_Card_Scheme.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pmed.1004565.ref016">
<span class="label">16.</span><cite>Kimpton JE, Carey IM, Threapleton CJD, Robinson A, Harris T, Cook DG, et al. Longitudinal exposure of English primary care patients to pharmacogenomic drugs: an analysis to inform design of pre-emptive pharmacogenomic testing. Br J Clin Pharmacol. 2019;85(12):2734–46. doi: 10.1111/bcp.14100

</cite> [<a href="https://doi.org/10.1111/bcp.14100" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6955399/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31454087/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Clin%20Pharmacol&amp;title=Longitudinal%20exposure%20of%20English%20primary%20care%20patients%20to%20pharmacogenomic%20drugs:%20an%20analysis%20to%20inform%20design%20of%20pre-emptive%20pharmacogenomic%20testing&amp;author=JE%20Kimpton&amp;author=IM%20Carey&amp;author=CJD%20Threapleton&amp;author=A%20Robinson&amp;author=T%20Harris&amp;volume=85&amp;issue=12&amp;publication_year=2019&amp;pages=2734-46&amp;pmid=31454087&amp;doi=10.1111/bcp.14100&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pmed.1004565.ref017">
<span class="label">17.</span><cite>PharmGKB and CPIC. Gene-specific information tables for CYP2C19. [cited 10 Feb 2025]. Available from: <a href="https://www.pharmgkb.org/page/cyp2c19RefMaterials" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.pharmgkb.org/page/cyp2c19RefMaterials</a></cite> [<a href="https://scholar.google.com/scholar_lookup?PharmGKB%20and%20CPIC.%20Gene-specific%20information%20tables%20for%20CYP2C19.%20%5Bcited%2010%20Feb%202025%5D.%20Available%20from:%20https://www.pharmgkb.org/page/cyp2c19RefMaterials" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pmed.1004565.ref018">
<span class="label">18.</span><cite>PharmGKB and CPIC. Gene-specific information tables for CYP2D6. [cited 12 Jun 2024]. Available from: <a href="https://www.pharmgkb.org/page/cyp2d6RefMaterials" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.pharmgkb.org/page/cyp2d6RefMaterials</a></cite> [<a href="https://scholar.google.com/scholar_lookup?PharmGKB%20and%20CPIC.%20Gene-specific%20information%20tables%20for%20CYP2D6.%20%5Bcited%2012%20Jun%202024%5D.%20Available%20from:%20https://www.pharmgkb.org/page/cyp2d6RefMaterials" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pmed.1004565.ref019">
<span class="label">19.</span><cite>Gaedigk A, Sangkuhl K, Whirl-Carrillo M, Klein T, Leeder JS. Prediction of CYP2D6 phenotype from genotype across world populations. Genet Med. 2017;19(1):69–76. doi: 10.1038/gim.2016.80

</cite> [<a href="https://doi.org/10.1038/gim.2016.80" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5292679/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27388693/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet%20Med&amp;title=Prediction%20of%20CYP2D6%20phenotype%20from%20genotype%20across%20world%20populations&amp;author=A%20Gaedigk&amp;author=K%20Sangkuhl&amp;author=M%20Whirl-Carrillo&amp;author=T%20Klein&amp;author=JS%20Leeder&amp;volume=19&amp;issue=1&amp;publication_year=2017&amp;pages=69-76&amp;pmid=27388693&amp;doi=10.1038/gim.2016.80&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pmed.1004565.ref020">
<span class="label">20.</span><cite>Skokou M, Karamperis K, Koufaki M-I, Tsermpini E-E, Pandi M-T, Siamoglou S, et al. Clinical implementation of preemptive pharmacogenomics in psychiatry. EBioMedicine. 2024;101:105009. doi: 10.1016/j.ebiom.2024.105009

</cite> [<a href="https://doi.org/10.1016/j.ebiom.2024.105009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10879811/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38364700/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=EBioMedicine&amp;title=Clinical%20implementation%20of%20preemptive%20pharmacogenomics%20in%20psychiatry&amp;author=M%20Skokou&amp;author=K%20Karamperis&amp;author=M-I%20Koufaki&amp;author=E-E%20Tsermpini&amp;author=M-T%20Pandi&amp;volume=101&amp;publication_year=2024&amp;pages=105009&amp;pmid=38364700&amp;doi=10.1016/j.ebiom.2024.105009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pmed.1004565.ref021">
<span class="label">21.</span><cite>Magavern EF, van Heel DA, Genes &amp; Health Research Team, Smedley D, Caulfield MJ. <em>CYP2C19</em> loss-of-function alleles are not associated with higher prevalence of gastrointestinal bleeds in those who have been prescribed antidepressants: analysis in a British-South Asian cohort. Br J Clin Pharmacol. 2023;89(11):3432–8. doi: 10.1111/bcp.15762

</cite> [<a href="https://doi.org/10.1111/bcp.15762" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37143396/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Clin%20Pharmacol&amp;title=CYP2C19%20loss-of-function%20alleles%20are%20not%20associated%20with%20higher%20prevalence%20of%20gastrointestinal%20bleeds%20in%20those%20who%20have%20been%20prescribed%20antidepressants:%20analysis%20in%20a%20British-South%20Asian%20cohort&amp;author=EF%20Magavern&amp;author=DA%20van%20Heel&amp;author=Team%20Genes%20&amp;%20Health%20Research&amp;author=D%20Smedley&amp;author=MJ%20Caulfield&amp;volume=89&amp;issue=11&amp;publication_year=2023&amp;pages=3432-8&amp;pmid=37143396&amp;doi=10.1111/bcp.15762&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<span>S1 Table. List of pharmacogenomic drugs, their associated gene(s) and prescriber category.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11949333/bin/pmed.1004565.s001.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pmed.1004565.s001.xlsx</a><sup> (9.9KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p">
<span>S2 Table. Number and percentage of adverse drug reactions associated with pharmacogenomic drugs stratified by decade.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11949333/bin/pmed.1004565.s002.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pmed.1004565.s002.xlsx</a><sup> (10.9KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="caption p">
<span>S3 Table. Number and percentage of adverse drug reaction reports associated with PREPARE drugs that have a pharmacogneomic indication for the gene SLCO1B1 stratified by decade.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11949333/bin/pmed.1004565.s003.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pmed.1004565.s003.xlsx</a><sup> (8.8KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="caption p">
<span>S4 Table. Number and percentage of adverse drug reaction reports associated with PREPARE drugs that have a pharmacogneomic indication for the gene CYP2D6 stratified by decade.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11949333/bin/pmed.1004565.s004.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pmed.1004565.s004.xlsx</a><sup> (12.3KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material5_reqid_"><div class="caption p">
<span>S5 Table. Number and percentage of adverse drug reaction reports associated with PREPARE drugs that have a pharmacogneomic indication for the gene CYP2C19 stratified by decade.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11949333/bin/pmed.1004565.s005.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pmed.1004565.s005.xlsx</a><sup> (10KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material6_reqid_"><div class="caption p">
<span>S6 Table. Number and percenateg of PGx assoicated adverse drug reactions stratified by prescriber category.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11949333/bin/pmed.1004565.s006.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pmed.1004565.s006.xlsx</a><sup> (10.8KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material7_reqid_"><div class="caption p">
<span>S7 Table. PGx (number and percentage) associated adverse drug reactions and the prescribing prevalence (number and percentage) over a 20-year period (1993–2013).</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11949333/bin/pmed.1004565.s007.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pmed.1004565.s007.xlsx</a><sup> (10.4KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material8_reqid_"><div class="caption p">
<span>S8 Table. Number and percentage of pharmacogenomic mitigatable adverse drug reactions of oestrogen drugs.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11949333/bin/pmed.1004565.s008.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pmed.1004565.s008.xlsx</a><sup> (10KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material9_reqid_"><div class="caption p">
<span>S9 Table. Psychiatric pharmacogenomic drugs stratified by type of adverse drug reaction (cardiac arrhythmia or other) and the level of seriousness.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11949333/bin/pmed.1004565.s009.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pmed.1004565.s009.xlsx</a><sup> (13KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material10_reqid_"><div class="caption p">
<span>S10 Table. Psychiatric pharmacogenomic adverse drug reactions stratified by level of seriousness.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11949333/bin/pmed.1004565.s010.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pmed.1004565.s010.xlsx</a><sup> (10.2KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material11_reqid_"><div class="caption p">
<span>S11 Table. Clinical Pharmacogenetics Implementation Consortium list of clinically actionable drugs with a pharmacogenomic indication and their associated genes.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11949333/bin/pmed.1004565.s011.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pmed.1004565.s011.xlsx</a><sup> (10.6KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material12_reqid_"><div class="caption p">
<span>S11. STROBE checklist.</span><p>(DOCX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11949333/bin/pmed.1004565.s012.docx" data-ga-action="click_feat_suppl" class="usa-link">pmed.1004565.s012.docx</a><sup> (32.8KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Data and code: Data used is openly available from the MHRA (<a href="https://yellowcard.mhra.gov.uk/idaps" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://yellowcard.mhra.gov.uk/idaps</a>). We have made available the code we used to compile the MHRA published csvs (<a href="https://github.com/whri-phenogenomics/yellow_card_pharmacogenomic_project/tree/main" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://github.com/whri-phenogenomics/yellow_card_pharmacogenomic_project/tree/main</a>)</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from PLOS Medicine are provided here courtesy of <strong>PLOS</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1371/journal.pmed.1004565"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/pmed.1004565.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.2 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/11949333/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/11949333/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11949333%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC11949333/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC11949333/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC11949333/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40146782/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC11949333/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40146782/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC11949333/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/11949333/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="WnArBDvMALa2DX2op73GL4n4s7Zs5Wjrexw1qy5QY2dGVNoeTVhhUv4Zbn32ssdP">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-B7-tgZZA.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-BLbQGH8u.js"></script>
    
    

    </body>
</html>
